One expert urged caution, saying, “Sometimes this smells like expanding the market” in the absence of high-quality RCT data.

Researchers saw some differences between valve types; while provocative, these data need confirmation, observers say.

The dedicated device can lacerate bioprosthetic leaflets poised to cause coronary obstruction—and does it quickly.

The results are intuitive, but whether better stent expansion will translate into better clinical outcomes is still up for ...

The simple tool includes just three factors, making it easy to use by the nonclinical staff most likely to use it.

BASEL, Switzerland—Low-dose colchicine doesn’t significantly reduce MACE in patients who have had a nonsevere ischemic stroke ...

The first trial to test shortened DAPT in coronary DCBs, REC-CAGEFREE II builds upon the evidence available for DES PCI.

The Indian-made valve, available in nine sizes, still needs to deliver on outcomes in a randomized trial, experts agreed.

Interventionalists were stunned by the results—a clear win for PCI/TAVI—but surgeons argued the devil is in the details.

The findings mirror research from other parts of the world, highlighting the need to address social determinants of health.

Initiated by Abbott/Thoratec and deemed Class I by the FDA, the recall is in response to reports of 70 injuries and two ...

A few simple questions that gauge whether symptoms are—or aren’t—typical could provide valuable insights to drive care.